AstraZeneca vaccine effective against UK variant, claims Oxford University
The leading British educational institute, the Oxford University, has claimed that its researchers have found AstraZeneca Covid-19 vaccine effective against corona variant that emerged as a new threat across the United Kingdom.
The university said that an ongoing assessment of its effectiveness showed that it had “similar efficacy” to other coronavirus strains. The vaccine was developed by the university in collaboration with the British-Swedish pharmaceutical firm,
“Data from our trials… in the United Kingdom indicate that the vaccine not only protects against the original pandemic virus, but also protects against the novel variant,” said Andrew Pollard, co-chief investigator on the Oxford vaccine trial.
In September, 2020, a case of the coronavirus variant was reported in Southeast England, which has now become a new normal in virus-related infections reported from all over the country and even in other countries as well.
“We have always expected that as the pandemic continues, new variants will begin to become dominant amongst the viruses that are circulating and that eventually a new version of the vaccine… would be required,” said Sarah Gilbert, co-chief investigator of the Oxford trial.
However, it is less clear how well the vaccines developed so far will work against several other variants that have emerged around the world, in particular a strain from South Africa that is causing concern.